Does ROSUVASTATIN Cause Vitreous floaters? 17 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Vitreous floaters have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.1% of all adverse event reports for ROSUVASTATIN.
17
Reports of Vitreous floaters with ROSUVASTATIN
0.1%
of all ROSUVASTATIN reports
0
Deaths
2
Hospitalizations
How Dangerous Is Vitreous floaters From ROSUVASTATIN?
Of the 17 reports, 2 (11.8%) required hospitalization.
Is Vitreous floaters Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Vitreous floaters?
AFLIBERCEPT (690)
BROLUCIZUMAB-DBLL (479)
RANIBIZUMAB (458)
BEVACIZUMAB (323)
ADALIMUMAB (300)
DUPILUMAB (300)
CIPROFLOXACIN (189)
FINGOLIMOD (129)
FARICIMAB\FARICIMAB-SVOA (123)
UPADACITINIB (112)
Which ROSUVASTATIN Alternatives Have Lower Vitreous floaters Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN